Figure 2
RASSF1A immunoexpression in an endometrial carcinoma without RASSF1A-promoter hypermethylation. Notice the strong cytoplasmic staining (a, b).
Figure 2 | Modern Pathology
RASSF1A immunoexpression in an endometrial carcinoma without RASSF1A-promoter hypermethylation. Notice the strong cytoplasmic staining (a, b).
